Wall Street Analysts Believe Urogen Pharma (URGN) Could Rally 209.92%: Here's is How to Trade
Portfolio Pulse from
Wall Street analysts have set a mean price target for Urogen Pharma (URGN) that suggests a potential 209.9% upside. Despite the historical ineffectiveness of this metric, the consensus among analysts in raising earnings estimates indicates a positive outlook for the stock.
December 03, 2024 | 12:00 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have set a mean price target for Urogen Pharma (URGN) indicating a potential 209.9% upside. The consensus in raising earnings estimates suggests a positive outlook.
The article highlights a significant potential upside for URGN based on analysts' price targets and consensus on raised earnings estimates. This suggests a positive sentiment and potential rally in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100